The research landscape concerning environmental factors in neurodevelopmental disorders: Endocrine disrupters and pesticides-A review
This study contributes to analyzing their effect on the molecular mechanism in maternal and infant thyroid function, essential for infant neurodevelopment, and whose alteration has been associated with various neurodevelopmental disorders. The results provide scientific evidence of the association that exists between the environmental neurotoxins and various neurodevelopmental disorders. In addition, other possible molecular mechanisms by which pesticides and endocrine disruptors may be associated with neurodevelopmental disorders are being discussed.PMID:38561126 | DOI:10.1016/j.yfrne.2024.101132 (Source: Frontiers in Neuroendocrinology)
Source: Frontiers in Neuroendocrinology - April 1, 2024 Category: Endocrinology Authors: Rebeca Mira S ánchez Juan Felipe Bermeo Losada Juan Antonio Mar ín Martínez Source Type: research
The research landscape concerning environmental factors in neurodevelopmental disorders: Endocrine disrupters and pesticides-A review
This study contributes to analyzing their effect on the molecular mechanism in maternal and infant thyroid function, essential for infant neurodevelopment, and whose alteration has been associated with various neurodevelopmental disorders. The results provide scientific evidence of the association that exists between the environmental neurotoxins and various neurodevelopmental disorders. In addition, other possible molecular mechanisms by which pesticides and endocrine disruptors may be associated with neurodevelopmental disorders are being discussed.PMID:38561126 | DOI:10.1016/j.yfrne.2024.101132 (Source: Frontiers in Neuroendocrinology)
Source: Frontiers in Neuroendocrinology - April 1, 2024 Category: Endocrinology Authors: Rebeca Mira S ánchez Juan Felipe Bermeo Losada Juan Antonio Mar ín Martínez Source Type: research
The research landscape concerning environmental factors in neurodevelopmental disorders: Endocrine disrupters and pesticides-A review
This study contributes to analyzing their effect on the molecular mechanism in maternal and infant thyroid function, essential for infant neurodevelopment, and whose alteration has been associated with various neurodevelopmental disorders. The results provide scientific evidence of the association that exists between the environmental neurotoxins and various neurodevelopmental disorders. In addition, other possible molecular mechanisms by which pesticides and endocrine disruptors may be associated with neurodevelopmental disorders are being discussed.PMID:38561126 | DOI:10.1016/j.yfrne.2024.101132 (Source: Frontiers in Neuroendocrinology)
Source: Frontiers in Neuroendocrinology - April 1, 2024 Category: Endocrinology Authors: Rebeca Mira S ánchez Juan Felipe Bermeo Losada Juan Antonio Mar ín Martínez Source Type: research
The research landscape concerning environmental factors in neurodevelopmental disorders: Endocrine disrupters and pesticides-A review
This study contributes to analyzing their effect on the molecular mechanism in maternal and infant thyroid function, essential for infant neurodevelopment, and whose alteration has been associated with various neurodevelopmental disorders. The results provide scientific evidence of the association that exists between the environmental neurotoxins and various neurodevelopmental disorders. In addition, other possible molecular mechanisms by which pesticides and endocrine disruptors may be associated with neurodevelopmental disorders are being discussed.PMID:38561126 | DOI:10.1016/j.yfrne.2024.101132 (Source: Frontiers in Neuroendocrinology)
Source: Frontiers in Neuroendocrinology - April 1, 2024 Category: Endocrinology Authors: Rebeca Mira S ánchez Juan Felipe Bermeo Losada Juan Antonio Mar ín Martínez Source Type: research
The research landscape concerning environmental factors in neurodevelopmental disorders: Endocrine disrupters and pesticides-A review
This study contributes to analyzing their effect on the molecular mechanism in maternal and infant thyroid function, essential for infant neurodevelopment, and whose alteration has been associated with various neurodevelopmental disorders. The results provide scientific evidence of the association that exists between the environmental neurotoxins and various neurodevelopmental disorders. In addition, other possible molecular mechanisms by which pesticides and endocrine disruptors may be associated with neurodevelopmental disorders are being discussed.PMID:38561126 | DOI:10.1016/j.yfrne.2024.101132 (Source: Frontiers in Neuroendocrinology)
Source: Frontiers in Neuroendocrinology - April 1, 2024 Category: Endocrinology Authors: Rebeca Mira S ánchez Juan Felipe Bermeo Losada Juan Antonio Mar ín Martínez Source Type: research
The research landscape concerning environmental factors in neurodevelopmental disorders: Endocrine disrupters and pesticides-A review
This study contributes to analyzing their effect on the molecular mechanism in maternal and infant thyroid function, essential for infant neurodevelopment, and whose alteration has been associated with various neurodevelopmental disorders. The results provide scientific evidence of the association that exists between the environmental neurotoxins and various neurodevelopmental disorders. In addition, other possible molecular mechanisms by which pesticides and endocrine disruptors may be associated with neurodevelopmental disorders are being discussed.PMID:38561126 | DOI:10.1016/j.yfrne.2024.101132 (Source: Frontiers in Neuroendocrinology)
Source: Frontiers in Neuroendocrinology - April 1, 2024 Category: Endocrinology Authors: Rebeca Mira S ánchez Juan Felipe Bermeo Losada Juan Antonio Mar ín Martínez Source Type: research
The research landscape concerning environmental factors in neurodevelopmental disorders: Endocrine disrupters and pesticides-A review
This study contributes to analyzing their effect on the molecular mechanism in maternal and infant thyroid function, essential for infant neurodevelopment, and whose alteration has been associated with various neurodevelopmental disorders. The results provide scientific evidence of the association that exists between the environmental neurotoxins and various neurodevelopmental disorders. In addition, other possible molecular mechanisms by which pesticides and endocrine disruptors may be associated with neurodevelopmental disorders are being discussed.PMID:38561126 | DOI:10.1016/j.yfrne.2024.101132 (Source: Frontiers in Neuroendocrinology)
Source: Frontiers in Neuroendocrinology - April 1, 2024 Category: Endocrinology Authors: Rebeca Mira S ánchez Juan Felipe Bermeo Losada Juan Antonio Mar ín Martínez Source Type: research
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research
